Instructor Michael McCulloch, LAc MPH PhD

Distance Learning Class (Recorded from a live broadcast on 3/20/20)

This course is pending approval by the California Acupuncture Board, Provider #680, for 2 hours of continuing education in category 1 as "distant learning" credits. This course is pending approval by the NCCAOM, Provider #683, for 2 hours of continuing education in AOM-BIO as "distant learning" credits. To receive distant learning credit, a test will be administered by email once the course is approved.

This class is being taught as a collaboration with the Pine Street Foundation.

Course Description

During this 2 hour class, we will review modern traditional Chinese medicine research and training for cold and flu. Traditional Chinese medical (TCM) practitioners often see patients with cold and flu symptoms. While the treatment of cold and flu symptoms in general is described in the traditional literature and in some recently published textbooks, the results of modern research on TCM for cold and flu is more elusive to most providers, and therefore not generally understood. Topics will include:

Connections between modern TCM cold/flu research, and their traditional training

Connections between modern TCM cold/flu research, and their traditional training Understanding of how Chinese herbal medicine is active in supporting the body’s efforts to defend against the virus

Research-based insights into how Chinese herbal medicines, foods and other nutrients can reduce the immune system's inflammatory reaction known as the “cytokine storm”

What are the obligations with respect to infection control and preventing transmission, and treating patients

Evidence-based information on infection control and personal/public safety measures to take

How the body is affected by Coronavirus infection

Instructor Bio: Michael McCulloch, L.Ac., MPH, PhD



Michael is the Research Director at the Pine Street Foundation where their clinic specializes in creating innovative and integrative treatment programs for complex medical problems. Michael is an apprentice-trained acupuncturist at the Pine Street Clinic. He is public health trained through UC Berkeley's School of Public Health and has a PhD in Epidemiology. He is a published author of peer-reviewed papers discussing TCM for hepatitis B, lung, colon, and liver cancers along with canine scent detection for diagnosis of breast and lung cancers. The Pine Street Foundation has collaborated with researchers at the Chinese Academy of Sciences in Beijing, University of California at Berkeley, University of California at San Francisco, California Pacific Medical Center, the University of Maine, and Baylor University.

REGISTRATION

Visit our CEU product page to purchase this class. Price for this class is $40. You will receive further instructions with the recording link and class notes within 1 business day. Mayway is very pleased to collaborate with the Pine Street Foundation in presenting this important topic.

CONTINUING EDUCATION CREDITS

This course is pending approval by the California Acupuncture Board, Provider #680, for 2 hours of continuing education in category 1 as "distant learning" credits. This course is pending approval by the NCCAOM, Provider #683, for 2 hours of continuing education in AOM-BIO as distant learning credit. To receive distant learning credit, a test will be administered by email once the course is approved.

CANCELLATION POLICY

No refunds will be given for this class unless canceled by the course provider.

COUPON & HERBS FOR SALE

Attendees will receive a coupon for use on our website. (Use of coupon or purchase of Mayway herbal products is not required to attend a Mayway sponsored educational event.)

MATERIALS & HANDOUTS

An email will be sent with the recording link and handout.

CE Certificates

Those requiring Distant Learning certificates will be sent further instructions by email once the class approval has been processed.

Note: Currently there is no conclusive peer-reviewed research on herbs or herbal formulas regarding the treatment of COVID-19.